Paper40923698
Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis.
Fu X and 5 others. Kaohsiung J Med Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. Papers, record 40923698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40923698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oxidative Stress | Major topic |
| Atherosclerosis | Major topic |
| Rosuvastatin Calcium | Major topic |
| Plaque, Atherosclerotic | Major topic |
| Nuclear Receptor Co-Repressor 1 | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Male | |
| Up-Regulation | |
| Apolipoproteins E | |
| Myocytes, Smooth Muscle | |
| Mice, Inbred C57BL | |
| Diet, High-Fat | |
| Reactive Oxygen Species | |
| Muscle, Smooth, Vascular | |
| Disease Models, Animal | |
| Transcription, Genetic | |
| Cell Proliferation | |
| Aorta |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28868076 | Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells. | J Geriatr Cardiol | 2017 | https://conductscience.org/library/papers/28868076 | PubMed |
| 2 | 37781401 | Fat and inflammation: adipocyte-myeloid cell crosstalk in atherosclerosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37781401 | PubMed |
| 3 | 28625769 | Mechanisms of aortic dissection smooth muscle cell phenotype switch. | J Thorac Cardiovasc Surg | 2017 | https://conductscience.org/library/papers/28625769 | PubMed |
| 4 | 35459215 | Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35459215 | PubMed |
| 5 | 39524227 | An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39524227 | PubMed |
| 6 | 29702025 | DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21. | FASEB J | 2018 | https://conductscience.org/library/papers/29702025 | PubMed |
| 7 | 37978036 | RCOR1 improves neurobehaviors and neuron injury in rat cerebral palsy by Endothelin-1 targeting-induced Akt/GSK-3β pathway upregulation. | Brain Dev | 2024 | https://conductscience.org/library/papers/37978036 | PubMed |
| 8 | 35456556 | Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go? | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456556 | PubMed |
| 9 | 33568202 | Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities. | J Transl Med | 2021 | https://conductscience.org/library/papers/33568202 | PubMed |
| 10 | 37451421 | Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation. | Eur J Pharmacol | 2023 | https://conductscience.org/library/papers/37451421 | PubMed |
| 11 | 32083311 | Statin-mediated cholesterol depletion exerts coordinated effects on the alterations in rat vascular smooth muscle cell biomechanics and migration. | J Physiol | 2020 | https://conductscience.org/library/papers/32083311 | PubMed |
| 12 | 32648167 | Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia. | Am J Cardiovasc Drugs | 2020 | https://conductscience.org/library/papers/32648167 | PubMed |
| 13 | 31849973 | Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis. | Front Immunol | 2019 | https://conductscience.org/library/papers/31849973 | PubMed |
| 14 | 35832642 | Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35832642 | PubMed |
| 15 | 24788803 | Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases. | Drug Saf | 2014 | https://conductscience.org/library/papers/24788803 | PubMed |
| 16 | 38468335 | Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/38468335 | PubMed |
| 17 | 24530860 | The c10orf10 gene product is a new link between oxidative stress and autophagy. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24530860 | PubMed |
| 18 | 40923698 | Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/40923698 | PubMed |
| 19 | 18422395 | Rosuvastatin: a review of its effect on atherosclerosis. | Am J Cardiovasc Drugs | 2008 | https://conductscience.org/library/papers/18422395 | PubMed |
| 20 | 24388105 | Role of vascular smooth muscle cell in the inflammation of atherosclerosis. | BMB Rep | 2014 | https://conductscience.org/library/papers/24388105 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40923698 | Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/40923698 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40923698
GET https://conductscience.org/api/papers/v1/40923698/references?page=2